Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 4 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Results 21 - 22 of 22 : « Previous 1 2

Recs

0
Member Avatar Joree (31.43) Submitted: 11/3/2006 4:10:46 PM : Outperform Start Price: $49.87 LGND Score: -76.51

I like the objective of working on orphan illnesses as a way to support business while working on cancer as a longer shot.

Report this Post Reply | Reply | Permalink

Recs

0
Member Avatar Lippy2222 (< 20) Submitted: 9/17/2006 6:22:13 PM : Outperform Start Price: $46.65 LGND Score: -78.82

stockastic is crossing on the wat up

Report this Post Reply | Reply | Permalink
Results 21 - 22 of 22 : « Previous 1 2

Featured Broker Partners


Advertisement